BOB ICB
Menu
  • Home
  • About us
    • What is the Integrated Care System?
    • Our Board & Leadership
    • Board Meetings
      • Board Papers
    • Information Governance and Data Protection Policies
      • DPIAs
    • Who is Involved?
    • Get Involved
    • ICB Structure
  • Our places
  • Your health
    • Cataract surgery - your choices
    • Dentists
    • Continuing Healthcare
    • Personalised Care
      • Public
      • Professionals
    • Clinical Commissioning Policy Statements & IFRs
  • How we work
    • Key Publications
    • BOB ICB Newsletter
    • Constitution & Governance Arrangements
    • Register of Interests
    • Fair Processing Notice
    • Freedom of Information Requests
    • Expenditure Over £25K
    • Medicines Optimisation
    • Counter Fraud
    • NHS Community pharmacy, optometry and dental commissioning and complaints
    • Digital & Data
  • Our strategies and plans
    • Primary Care Strategy
    • Integrated Care Strategy
    • Joint Forward Plan
    • Local Transformation Plan
  • News
  • Contact us
    • Make a complaint
    • Safeguarding
    • Subject Access Requests
    • Freedom of Information Requests
    • Accessibility Statement
  • Home
  • Staff Zone
    • Login
  1. Home
  2. Clinical Commissioning Policy Statement Categories
  3. Ophthalmology

Ophthalmology

Buckinghamshire

  • BOBFPC5 - Anti-VEGF Treatments and Dexamethasone Implants for Macular Oedema caused by Central and Branch Retinal Vein Occlusion
  • TVPC45 - Sequential use of Biologic Therapy in Ophthalmology – Interim policy statement
  • BOBFPC60 - Cataract Removal in Adults – thresholds for surgery
  • BOBFPC70 - Ectropion and Entropion - Indications for Surgery
  • BOBFPC95 - Treatment of Chalazia
  • TVPC96 - Anti VEGFs for the Management of Sight-Threatening Rare Eye Conditions Involving Neo-Vascularisation
  • BOBFPC111 - Treatment with Anti-VEGF agents for Neovascular (Wet) Age-Related Macular Degeneration in Patients with ‘One Good Eye’
  • BOBFPC113 - Eyelid Surgery for Ptosis and Dermatochalasis

  • 27 - Filtered and Coloured Lenses

Oxfordshire

  • BOBFPC5 - Anti-VEGF Treatments and Dexamethasone Implants for Macular Oedema caused by Central and Branch Retinal Vein Occlusion
  • TVPC45 - Sequential use of Biologic Therapy in Ophthalmology – Interim policy statement
  • BOBFPC60 - Cataract Removal in Adults – thresholds for surgery
  • BOBFPC70 - Ectropion and Entropion - Indications for Surgery
  • BOBFPC95 - Treatment of Chalazia
  • TVPC96 - Anti VEGFs for the Management of Sight-Threatening Rare Eye Conditions Involving Neo-Vascularisation
  • BOBFPC111 - Treatment with Anti-VEGF agents for Neovascular (Wet) Age-Related Macular Degeneration in Patients with ‘One Good Eye’
  • BOBFPC113 - Eyelid Surgery for Ptosis and Dermatochalasis

 

 

Berkshire West

  • BOBFPC5 - Anti-VEGF Treatments and Dexamethasone Implants for Macular Oedema caused by Central and Branch Retinal Vein Occlusion
  • TVPC45 - Sequential use of Biologic Therapy in Ophthalmology – Interim policy statement
  • BOBFPC60 - Cataract Removal in Adults – thresholds for surgery
  • BOBFPC70 - Ectropion and Entropion - Indications for Surgery
  • BOBFPC95 - Treatment of Chalazia
  • TVPC96 - Anti VEGFs for the Management of Sight-Threatening Rare Eye Conditions Involving Neo-Vascularisation
  • BOBFPC111 - Treatment with Anti-VEGF agents for Neovascular (Wet) Age-Related Macular Degeneration in Patients with ‘One Good Eye’
  • BOBFPC113 - Eyelid Surgery for Ptosis and Dermatochalasis

 

Clinical Commissioning Policy Statement Categories

  • Aesthetics/Cosmetics
  • Complementary & Alternative Therapies
  • Dermatology
  • Ear, Nose & Throat (ENT)
  • Endocrinology
  • Gastroenterology
  • General Surgery
  • Guidance for Policy Exceptions
  • Infertility
  • Medicines
  • Mental Health
  • Musculoskeletal (MSK)
  • Neurology
  • NHS England
  • NICE Policies
  • Obstetrics & Gynaecology
  • Ophthalmology
  • Paediatrics & Child Health
  • Plastic Surgery
  • Podiatry
  • Private to NHS Funding
  • Radiology
  • Research Trial & NHS Funding
  • Rheumatology
  • Smoking Cessation before Planned Surgery
  • Urology
  • Vascular
  • © BOB ICB 2024 All rights reserved.
  • Accessibility
  • Cookie Policy
  • Site content & design: SCW CSU